⏳ Fetching live dividend data...
Home › Calculator › TNXP Dividend Calculator 2026
Tonix Pharmaceuticals Holding Corp. · NASDAQ
Price: $12.33 · Annual div: $2.00/share · Frequency: quarterly · Payout ratio: 50% · Ex-div: TBD
Click to apply scenario to the calculator
Year your monthly dividend income covers each expense (based on current settings)
$10,000 in TNXP → $11.7K in 10 years · $0.15/month
Tonix Pharmaceuticals Holding Corp., a clinical-stage biopharmaceutical company, focuses on discovering, acquiring, developing, and licensing therapeutics and diagnostics to treat and prevent human disease and alleviate suffering. Its portfolio includes immunology, rare disease, infectious disease, and central nervous system (CNS) product candidates. The company's immunology portfolio includes biologics to address organ transplant rejection, autoimmunity, and cancer, including TNX-1500, a humanized monoclonal antibody targeting CD40-ligand being developed for the prevention of allograft and xenograft rejection and for the treatment of autoimmune diseases. Its rare disease portfolio comprises TNX-2900 for the treatment of Prader-Willi syndrome. The company's infectious disease pipeline includes TNX-801, a vaccine to prevent smallpox and monkeypox; TNX-1840 and TNX-1850 that are live virus vaccines based on its recombinant pox vaccine (RPV) platform for COVID-19; TNX-3500, a small molecule antiviral drug to treat acute COVID-19; and TNX-102 SL, a small molecule drug to treat Long COVID, a chronic post-acute COVID-19 condition. Its CNS portfolio includes small molecules and biologics to treat pain, neurologic, psychiatric, and addiction conditions, including TNX-102 SL, which is in mid-Phase 3 development for the management of fibromyalgia; TNX-1900 that is in development for the prevention of migraine headache; and TNX-1300, a biologic designed to treat cocaine intoxication. The company was founded in 2007 and is headquartered in Chatham, New Jersey.
This calculation uses the DividendFlow Engine v6.0. Data is verified daily against SEC filings and FMP real-time feeds to ensure projection accuracy.
We'll send you a full breakdown of your projections, DRIP tips, and how to enable dividend reinvestment with your broker.
Free forever. No spam. Unsubscribe anytime. · Privacy Policy
Ready to invest? Open TNXP position with:
Real after-tax yield depends on where you live and how you hold TNXP.
| Account/Country | Tax Rate | After-tax Yield | Real Yield | $10K Annual Income |
|---|---|---|---|---|
| 🇺🇸 Roth IRA / 401k | 0% | 16.22% | 13.42% | $1,622 / yr |
| 🇺🇸 US Taxable (15%) ✓ | 15% | 13.79% | 10.99% | $1,379 / yr |
| 🇺🇸 US Taxable (20%) | 20% | 12.98% | 10.18% | $1,298 / yr |
| 🇬🇧 UK ISA | 0% | 16.22% | 13.42% | $1,622 / yr |
| 🇬🇧 UK Taxable | 8.75% | 14.80% | 12.00% | $1,480 / yr |
| 🇨🇦 TFSA | 0% | 16.22% | 13.42% | $1,622 / yr |
| 🇨🇦 CA Taxable | 25% | 12.16% | 9.36% | $1,217 / yr |
| 🇦🇺 Super (pension) | 15% | 13.79% | 10.99% | $1,379 / yr |
| 🇦🇺 AU Taxable | 30% | 11.35% | 8.55% | $1,135 / yr |
| 🇩🇪 DE Taxable | 26.375% | 11.94% | 9.14% | $1,194 / yr |
| 🇫🇷 FR Taxable | 30% | 11.35% | 8.55% | $1,135 / yr |
Real yield = after-tax yield minus US CPI of 2.8%. 12-month CPI (US BLS via FMP economic-indicators). Click any row to select. US withholding tax (30%, reducible by treaty) applies to non-US residents holding US stocks in taxable accounts.
12-month CPI (US BLS via FMP economic-indicators).
Based on current dividend of $2.00/share/yr · 🇺🇸 US Taxable (15%) · static projection (no growth assumed).
TNXP pays quarterly — 4 times per year. Next ex-div: TBD.
How TNXP compares to typical Healthcare averages.
Benchmarks: S&P 500 sector averages (2024–2026). Sources: Morningstar, Bloomberg, NAREIT. 5Y CAGR for TNXP sourced from FMP /financial-growth endpoint — real data, not estimates.
When executives buy their own stock, it's a signal they believe in the dividend's sustainability.
| Insider | Title | Type | Date | Shares | Price | Total Value |
|---|---|---|---|---|---|---|
| Buy | 2026-06-08 | 5,000 | $11.65 | $58.3K | ||
| Buy | 2026-06-09 | 5,000 | $11.79 | $59.0K | ||
| A-Award | 2026-05-12 | 22,700 | $13.28 | $301.5K | ||
| A-Award | 2026-05-12 | 22,700 | $13.28 | $301.5K | ||
| A-Award | 2026-05-12 | 22,700 | $13.28 | $301.5K | ||
| A-Award | 2026-05-12 | 22,700 | $13.28 | $301.5K | ||
| A-Award | 2026-05-12 | 22,700 | $13.28 | $301.5K | ||
| A-Award | 2026-05-12 | 22,700 | $13.28 | $301.5K | ||
| A-Award | 2026-05-12 | 22,700 | $13.28 | $301.5K | ||
| A-Award | 2026-05-12 | 22,700 | $13.28 | $301.5K |
Insider transactions sourced from SEC Form 4 filings via Financial Modeling Prep. See disclaimer.
Altman Z-Score predicts bankruptcy risk. Piotroski F-Score measures financial strength across 9 criteria. High scores → lower dividend cut risk. Data via FMP financial statements.
Insiders are net buyers — historically a positive signal for dividend sustainability. Last purchase: 2026-06-09
Dividend yields, payout ratios, and financial metrics are sourced from Financial Modeling Prep (FMP) and cross-referenced with SEC EDGAR filings. Data is cached and updated every 24 hours via our nightly refresh. DRIP projections are forward-looking estimates, not guarantees.
Educational purposes only. Not financial advice. DividendFlow is not a registered investment advisor. Projections generated by the TNXP dividend calculator are estimates based on historical data and user inputs. Actual future returns, stock prices, and dividend payments will vary. Dividends can be cut or suspended at any time. All investments carry risk, including the loss of principal. Please consult a qualified financial professional before making any investment decisions. Full disclaimer →
Real users. No sign-up required to leave a review.
“Finally a free dividend calculator that doesn't make me sign up or connect my brokerage. Entered SCHD and got the full DRIP projection in seconds. Bookmarked immediately.”
“I've been trying to figure out how much dividend income I'd need to retire. This tool showed me exactly — $400K in JEPI at 7% yield gives me $2,333/month. No calculator did that this clearly before.”
“Really solid passive income calculator. Covers everything: DRIP compounding, Roth IRA tax savings, DCA contributions. The year-by-year breakdown is what I was missing from other tools.”
“As someone planning retirement in 5 years, this dividend yield calculator showed me I need about 12% more in dividend stocks to hit my income target. Incredibly useful and completely free.”
“The Congress trades tracker is genius. Saw that several senators were buying O (Realty Income) and immediately ran it through the DRIP calculator. Bought 50 shares the next day.”
Reviews reflect users' personal experiences. Not financial advice.
Leave a review →